tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Lawrence Keusch, 114 are a BUY (86.36%), 16 are a HOLD (12.12%), 2 are a SELL (1.52%).
Analyst Lawrence Keusch, carries an average stock price target met ratio of 74.95% that have a potential upside of 19.6% achieved within 242 days.
Lawrence Keusch’s has documented 264 price targets and ratings displayed on 13 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on ZBH, Zimmer Biomet Holdings at 11-Feb-2026.
Analyst best performing recommendations are on AVTR (AVANTOR).
The best stock recommendation documented was for HAE (HAEMONETICS) at 8/5/2020. The price target of $93 was fulfilled within 35 days with a profit of $16.89 (22.19%) receiving and performance score of 6.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Nov-2019
$14
$0.48 (3.55%)
$17
10 months 25 days ago
(07-May-2025)
9/11 (81.82%)
$1.42 (11.29%)
164
Hold Since 25-Jul-2023
$34
2 years 8 months 7 days ago
(25-Jul-2023)
6/14 (42.86%)
$11.59 (51.72%)
153
Buy Since 22-May-2023
$31
$17.48 (129.29%)
$30
2 years 10 months 10 days ago
(22-May-2023)
5/6 (83.33%)
$7.45 (31.63%)
437
Sell
$24
$-2.79 (-10.41%)
$28
3 years 5 months 20 days ago
(11-Oct-2022)
2/4 (50%)
$3.54 (12.24%)
19
Hold Since 03-Nov-2021
$40
$26.48 (195.86%)
$45
4 years 4 months 29 days ago
(03-Nov-2021)
3/5 (60%)
$3.98 (11.05%)
100
Which stock is Lawrence Keusch is most bullish on?
Which stock is Lawrence Keusch is most reserved on?
What Year was the first public recommendation made by Lawrence Keusch?
